Dr S. Shahzad Mustafa looks ahead to ACAAI 2025, which will highlight advances in chronic urticaria treatment and ...

A cohort study finds no significant differences in height among children with inflammatory diseases treated with JAK ...

A wrist-worn, AI-driven transcutaneous peripheral nerve stimulator is linked to greater improvement in patients with ...

Muscle dysmorphia is increasing in Europe as social media and gym culture drive compulsive exercise and steroid use, ...

The stool-based test picks up colorectal cancers despite prior polypectomy, but many do not receive the recommended ...

Sean Virani, MD, lead author of the new guidelines and president of the CCS, explained that the guidelines use the term ...

An obesity medicine specialist’s thoughts on reducing the burden of prior authorization, documentation, and follow-ups.

In two multicenter trials, separate balloon angioplasty platforms were noninferior to lithotripsy for treatment of calcified ...

The cumulative use of strong anticholinergics is associated with an increased risk for dementia in a dose-response pattern; ...

Fueled by a handful of trials and word-of-mouth buzz, low-dose naltrexone is gaining momentum among patients and some doctors ...

An expert in gout clinical trials questions whether ethical considerations for such trials need updating to emphasize patient ...

While acknowledging the challenges to using SDOH information in practice, a presenter at the American College of Rheumatology ...